MarketCapExport financials
Nu Skin Enterprises (NUS)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Nu Skin Enterprises Income Statement 2025-2007 | NUS
Brief overview of financial results at Nu Skin Enterprises
This overview is based on financial performance over the past five years. Revenue at Nu Skin Enterprises moved from 2.4 billion dollars in 2019 to 1.7 billion dollars in 2024. Across the full period, sales moved by −28.4%; the average annual rate was −6.5%. Sales followed a declining trajectory over the five years.
The gross result shifted from 1.8 billion dollars to 1.2 billion dollars, or −35.7%. The relationship between sales and direct costs deteriorated. Comparing the endpoints gives gross margins of 76% and 68.2%. The business retained less gross profit from each unit of revenue.
EBITDA changed from 344 million dollars to −81.8 million dollars (−123.8%). Changes in revenue did not translate into comparable EBITDA performance. EBITDA margin was 14.2% at the start and −4.7% at the end. A lower EBITDA share weakens the quality of the result.
The final result was $174 million initially and −$147 million in the final year. Profit turned into a loss, the most concerning signal in the results.
The five-year change in capitalization reached −77.5%: from 1.7 billion dollars to 373 million dollars. Capitalization grew more slowly than the underlying results.
What the figures show
Signs of deterioration dominate the five-year picture. The overall view is constrained by pressure on operating profitability, pressure from direct costs and declining net profitability. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Nu Skin Enterprises
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
418 M | 373 M | 626 M | 1.23 B | 2.38 B | 2.89 B | 1.66 B | 3.23 B | 3.31 B | 2.87 B | 1.84 B | 2.42 B | 4.96 B | 2.53 B | 3.13 B | 1.75 B | 947 M | 1.08 B | - |
Shares |
49.3 M | 49.7 M | 49.7 M | 50 M | 50.2 M | 52.3 M | 55.5 M | 55.2 M | 52.8 M | 55.4 M | 58 M | 59.1 M | 58.6 M | 60.6 M | 62.1 M | 62.4 M | 63.3 M | 63.5 M | - |
Historical Prices |
8.49 | 7.51 | 12.6 | 24.5 | 47.4 | 55.3 | 29.9 | 58.5 | 62.8 | 44.1 | 25.9 | 32.5 | 66.3 | 32.3 | 37.5 | 28 | 14.9 | 17.1 | 17.6 |
Net Income |
160 M | -147 M | 8.6 M | 105 M | 147 M | 191 M | 174 M | 122 M | 129 M | 143 M | 133 M | 189 M | 365 M | 222 M | 153 M | 136 M | 89.8 M | 65.3 M | - |
Revenue |
1.49 B | 1.73 B | 1.97 B | 2.23 B | 2.7 B | 2.58 B | 2.42 B | 2.68 B | 2.28 B | 2.21 B | 2.25 B | 2.57 B | 3.18 B | 2.17 B | 1.74 B | 1.54 B | 1.33 B | - | - |
Cost of Revenue |
454 M | 550 M | 612 M | 631 M | 675 M | 658 M | 581 M | 634 M | 502 M | 500 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
1.03 B | 1.18 B | 1.36 B | 1.59 B | 2.02 B | 1.92 B | 1.84 B | 2.04 B | 1.78 B | 1.71 B | 1.76 B | 2.09 B | 2.67 B | 1.82 B | 1.42 B | 1.26 B | 1.09 B | 1.02 B | - |
Operating Income |
65.8 M | -152 M | 48.3 M | 111 M | 234 M | 258 M | 267 M | 241 M | 274 M | 231 M | 245 M | 352 M | 554 M | 341 M | 234 M | 217 M | 148 M | 125 M | - |
Interest Expense |
- | - | 25.6 M | 13.5 M | 11 M | 13.1 M | 19.2 M | 21.8 M | 22.2 M | 15.6 M | 7.9 M | 5.7 M | 3 M | 5.2 M | 4.8 M | 5.8 M | 6.9 M | - | - |
EBITDA |
118 M | -81.8 M | 119 M | 183 M | 310 M | 332 M | 344 M | 324 M | 346 M | 304 M | 316 M | 407 M | 589 M | 374 M | 267 M | 247 M | 176 M | 156 M | - |
Operating Expenses |
966 M | 1.33 B | 1.31 B | 1.48 B | 1.79 B | 1.67 B | 1.57 B | 1.73 B | 1.5 B | 1.48 B | 1.51 B | 1.74 B | 2.12 B | 1.48 B | 1.19 B | 1.05 B | 940 M | 894 M | - |
General and Administrative Expenses |
432 M | 479 M | 547 M | 556 M | 666 M | 647 M | 616 M | 662 M | 565 M | -368 M | 561 M | 622 M | 640 M | 505 M | 436 M | 401 M | 369 M | 360 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Nu Skin Enterprises
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
49.4 M | 49.8 M | - | 49.4 M | 49.4 M | 49.8 M | - | 49.7 M | 49.7 M | 49.5 M | - | 49.9 M | 49.9 M | 49.6 M | - | 50.2 M | 50.4 M | 50 M | - | 50.1 M | 50.1 M | 50.7 M | - | 51.3 M | 51.9 M | 55.1 M | - | 55.5 M | 55.5 M | 55.4 M | - | 55.6 M | 55.6 M | 54 M | - | 52.9 M | 52.9 M | 52.7 M | - | 56 M | 56 M | 56 M | - | 57.7 M | 58.5 M | 59 M | - | 59.2 M | 59.1 M | 58.9 M | - | 58.7 M | 58.6 B | 58.4 B | - | 59.8 B | 61.7 B | 62.2 M | - | 62.3 M | 61.8 M | 61.9 K | 402 K | 62.9 M | 63.1 M |
Net Income |
21.1 M | 108 M | - | 17.1 M | 21.1 M | 108 M | - | 8.3 M | -118 M | -533 K | - | -37 M | 26.9 M | 11.4 M | - | -25.4 M | 34.2 M | 38.7 M | - | 49.7 M | 59.3 M | 47.4 M | - | 56.3 M | 41.9 M | 19.7 M | - | 44.1 M | 46.3 M | 43 M | - | 53.1 M | 51 M | 35.5 M | - | 41.7 M | 42 M | 27.5 M | - | 56.9 M | 44.7 M | 3.32 M | 35.8 M | 16.3 M | 44.7 M | 36.3 M | 46.5 M | 68.3 M | 19.5 M | 54.9 M | 125 M | 111 M | 74.4 M | 54.3 M | 59.2 M | 54.2 M | 60.4 M | 47.8 M | 49.5 M | 46.8 M | 41.7 M | 15.3 M | 5.82 M | 25.6 M | 22.1 M |
Revenue |
386 M | 364 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 605 M | - | 641 M | 704 M | 677 M | - | 703 M | 612 M | 518 M | - | 590 M | 624 M | 624 M | - | 675 M | 704 M | 616 M | - | 564 M | 550 M | 499 M | - | 604 M | 600 M | 472 M | - | 571 M | 560 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
120 M | 118 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 161 M | - | 159 M | 172 M | 171 M | - | 183 M | 154 M | 126 M | - | 140 M | 154 M | 147 M | - | 157 M | 169 M | 146 M | - | 121 M | 122 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
266 M | 247 M | - | 257 M | 266 M | 247 M | - | 301 M | 307 M | 294 M | - | 292 M | 365 M | 348 M | - | 364 M | 413 M | 443 M | - | 482 M | 532 M | 506 M | - | 520 M | 458 M | 392 M | - | 450 M | 469 M | 477 M | - | 518 M | 536 M | 470 M | - | 443 M | 429 M | 388 M | - | 478 M | 472 M | 334 M | 451 M | 419 M | 450 M | 438 M | 503 M | 530 M | 494 M | 564 M | 891 M | 768 M | 560 M | 451 M | 484 M | 433 M | 482 M | 380 M | 415 M | 358 M | 353 M | 295 M | 243 M | 272 M | 262 M |
Operating Income |
30.8 M | -9.9 M | - | 21.6 M | 30.8 M | -9.9 M | - | 18.2 M | -126 M | 8.82 M | - | -26.4 M | 42.5 M | 16.1 M | - | -20.3 M | 51.5 M | 52.1 M | - | 65.4 M | 85.4 M | 62.9 M | - | 74.2 M | 58.1 M | 36.6 M | - | 69.9 M | 74.2 M | 68.7 M | - | 80.7 M | 82.8 M | 59 M | - | 64.4 M | 64.7 M | 46.3 M | - | 82.4 M | 79.8 M | 8.15 M | 61.7 M | 42.5 M | 71.8 M | 68.6 M | 91.3 M | 105 M | 54.7 M | 101 M | 189 M | 168 M | 115 M | 82.6 M | 88.9 M | 82.4 M | 97.9 M | 71.6 M | 75.6 M | 67.2 M | 66 M | 24.9 M | 29.9 M | 40.9 M | 34.5 M |
Interest Expense |
- | - | - | - | - | - | - | 6.5 M | 6.72 M | 7.32 M | - | 7.54 M | 5.77 M | 4.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
43.8 M | 4.3 M | - | 33.7 M | 43.8 M | 4.3 M | - | 35.6 M | -108 M | 27.3 M | - | -8.17 M | 59.7 M | 33 M | - | -2.11 M | 70.2 M | 69.3 M | - | 85.3 M | 105 M | 81.3 M | - | 92.1 M | 76.3 M | 55.7 M | - | 89.2 M | 93.3 M | 88.3 M | - | 103 M | 104 M | 77.9 M | - | 81.8 M | 82.2 M | 63.9 M | - | 101 M | 97.5 M | 25.1 M | 61.7 M | 94.6 M | 106 M | 85.2 M | 91.3 M | 144 M | 79.7 M | 113 M | 189 M | 192 M | 130 M | 90.2 M | 88.9 M | 108 M | 115 M | 80.1 M | 75.6 M | 91.2 M | 81.9 M | 32.8 M | 38.9 M | 47.8 M | 34.5 M |
Operating Expenses |
235 M | 257 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 391 M | - | 417 M | 447 M | 444 M | - | 446 M | 400 M | 356 M | - | 380 M | 395 M | 408 M | - | 437 M | 453 M | 411 M | - | 379 M | 364 M | 342 M | - | 396 M | 392 M | 326 M | - | 376 M | 378 M | 370 M | - | 425 M | 439 M | 463 M | - | 600 M | 445 M | 369 M | - | 357 M | 400 M | 315 M | - | 291 M | 287 M | 270 M | 213 M | 231 M | 227 M |
General and Administrative Expenses |
107 M | 113 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 149 M | - | 161 M | 169 M | 168 M | - | 165 M | 152 M | 150 M | - | 148 M | 149 M | 159 M | - | 166 M | 180 M | 153 M | - | 143 M | 135 M | 133 M | - | 141 M | 144 M | 130 M | - | 136 M | 139 M | 136 M | - | 161 M | 156 M | 150 M | - | 163 M | 148 M | 136 M | - | 121 M | 132 M | 112 M | - | 106 M | 104 M | 101 M | 93.6 M | 89.8 M | 88.7 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Nu Skin Enterprises (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
The Clorox Company
CLX
|
$ 106.6 | 1.01 % | $ 12.9 B |  USA |
 |
The Estée Lauder Companies
EL
|
$ 113.35 | 0.17 % | $ 41.1 B | USA |
 |
Unilever PLC
UL
|
$ 66.48 | -0.2 % | $ 145 B |  Britain |
 |
Colgate-Palmolive Company
CL
|
$ 98.06 | 0.12 % | $ 79.3 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 168.81 | 0.29 % | $ 394 B | USA |
 |
United-Guardian
UG
|
$ 9.01 | 1.81 % | $ 41.4 M | USA |
 |
USANA Health Sciences
USNA
|
$ 13.1 | -5.42 % | $ 243 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 111.77 | 0.41 % | $ 27.1 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 110.78 | -1.03 % | $ 36.8 B | USA |
 |
Hims & Hers Health
HIMS
|
$ 19.1 | -16.76 % | $ 4.3 B | USA |
 |
Coty
COTY
|
$ 4.34 | 2.73 % | $ 3.81 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 118.5 | -0.71 % | $ 6.9 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.44 | -1.36 % | $ 7.84 M |  China |
 |
Helen of Troy Limited
HELE
|
$ 38.19 | 2.28 % | $ 878 M |  Bermuda |
 |
Newell Brands
NWL
|
$ 5.94 | 0.76 % | $ 2.48 B | USA |
 |
Acme United Corporation
ACU
|
$ 70.35 | 1.6 % | $ 266 M | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 29.61 | 0.25 % | $ 1.41 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 4.64 | -12.29 % | $ 58.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.62 | -3.69 % | $ 16.4 M | USA |
 |
Inter Parfums
IPAR
|
$ 135.62 | -0.4 % | $ 4.35 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 10.89 | -1.23 % | $ 196 M | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.66 | -0.75 % | $ 2.28 B | USA |